Cancer Research UK -
This position paper finds that Covid-19 has worsened pre-existing barriers to clinical cancer research and recovering to a pre-pandemic ‘normal’ for research won’t be enough to deliver world-class cancer outcomes. Instead, the UK government must choose to go beyond recovery by expanding clinical research capacity, transforming how research is delivered, and supporting innovative cancer research.